Pioneering work based on science

Our deep science capabilities form the bedrock of our work enabling us to innovate for patients. Our investment in complex chemistry and biology have led us to several firsts. In India, we were among the first to export APIs at scale and introduce many new molecules. We were the first in India to initiate novel drug discovery in the 1990s and to receive 180-day exclusivity from the USFDA in the 2000s. We focus on being first to market, helping us deliver on our promises.